How we work with patient groups

PatientView firmly believes that the views of patient groups should be considered in all important healthcare decisions and play an important role in ensuring patients’ voices are heard by the pharmaceutical industry.


We are working to build bridges worldwide between patients and healthcare, providing patient groups with a voice and a platform while helping companies to understand patient insights and how to use them to react to and improve on issues.

Over the last 20 years, we have developed and maintained relationships with patient advocacy groups across most therapy areas and in almost every country worldwide.

PatientView’s owned studies are conducted entirely independently, so no pharmaceutical funding is involved. PatientView funds these whole exercises by selling our products to industry (including to leading pharma companies), to governments, and to national and international drug-regulatory bodies.


Contact us below for more information or to sign-up to PatientView’s mailing list:

    Patient groups and health campaigners can have their voices and opinions heard directly by pharma by taking part in our annual surveys which are fully anonymised. Read about our research below:

    The Corporate Reputation of Pharma 

    Each year from November to February we invite thousands of Patient Groups to take our survey on The Corporate Reputation of Pharma. This is an opportunity for patient groups to have their voices heard, and share if pharma has met their needs and expectations. If the answer is no, there is an opportunity to influence how the industry and individual companies could improve.

    How can this help your patient group?

    Many pharma companies are finally beginning to build their strategies around patients, and the feedback you provide influences their approach. As they carefully track the results from PatientView’s annual corporate-reputation surveys, your real-world insights make a true difference in enabling them to help you.

    Patient groups wishing to take part in the Corporate Reputation Survey for 2023/24

    Please click on the link below where you will find invitations and survey links in 22 languages

    Questionnaires for 2023/24

    You can also contact to find out more before taking the survey. 

    Pharma and ESG: the Patient Perspective 

    In 2023, PatientView published ‘Pharma and ESG: the Patient Perspective’ which aims to get the patient voice involved in pharma and ESG. The report draws on the analyses, insights and views of 832 patient groups worldwide to ensure that the patient voice is more fully represented in pharma’s ESG priorities in the future.

    To be updated in 2024.

    Learn more about Pharma and ESG.